Wijngaard Peter

Insider profile

Performance

Overall performance
2.4

Performance over holding periods
2.4
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 58% 68% 82%
Transactions
8 100% Buy
34 71% Buy
47 69% Buy
Wijngaard Peter's trades of Hepion Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-11-28 2023-11-27 B Purchase
87,784 -36.0%
412.41
US$987,473
87,784 -36.0% 412.41 US$987,473
2023-11-28 2023-11-24 B Purchase
62,394 +3.2%
335.49
US$1,912,556
62,394 +3.2% 335.49 US$1,912,556
2023-09-20 2023-09-19 B Purchase
18,353 -8.0%
420.00
US$515,436
18,353 -8.0% 420.00 US$515,436
2023-09-20 2023-09-15 B Purchase
861 +32.6%
5.37
US$4,624
861 +32.6% 5.37 US$4,624
2023-09-20 2023-09-15 B Purchase
139 +5.6%
5.45
US$758
139 +5.6% 5.45 US$758
2023-09-20 2023-09-15 B Purchase
1,000 +66.6%
5.82
US$5,820
1,000 +66.6% 5.82 US$5,820
2021-02-18 2021-02-16 B Purchase
10,000 +50.0%
2.20
US$22,000
10,000 +50.0% 2.20 US$22,000
2020-12-21 2020-12-18 B Purchase
20,000 +inf%
1.91
US$38,200
20,000 +inf% 1.91 US$38,200